Author Correction: Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results
Year: 2024
Type: erratum
DOI: 10.17615/czch-8f88
Authors: Courtney, Amy N., Zhang, Chunchao, Rathi, Purva, Xu, Xin, Subramaniam, Meena, Zhang, Huimin, Wang, Tao, Amador, Claudia Martinez, Demberg, Thorsten, Montalbano, Antonino, Grilley, Bambi, Barragan, Gabriel A., Wood, Michael S., Heczey, Andras, Sher, Andrew C., Ghatwai, Nisha, Metelitsa, Leonid S., Tian, Gengwen, Dotti, Gianpietro, Xu, Chenling, Sachar, Chirag, Weiss, Brian D., Wells, Daniel K., Thakkar, Sachin G., Li, Yanchuan, Mehta, Birju, Guo, Linjie, Di Pierro, Erica J.
Institution: University of North Carolina at Chapel Hill
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4403559729
